Paul J. Mellett
2018
In 2018, Paul J. Mellett earned a total compensation of $1.4M as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $149,379 |
---|---|
Option Awards | $604,010 |
Salary | $394,937 |
Stock Awards | $254,100 |
Other | $18,851 |
Total | $1,421,277 |
Mellett received $604K in option awards, accounting for 42% of the total pay in 2018.
Mellett also received $149.4K in non-equity incentive plan, $394.9K in salary, $254.1K in stock awards and $18.9K in other compensation.
Rankings
In 2018, Paul J. Mellett's compensation ranked 7,427th out of 14,244 executives tracked by ExecPay. In other words, Mellett earned more than 47.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,427 | 48th |
Manufacturing | 2,878 | 50th |
Chemicals And Allied Products | 1,080 | 49th |
Drugs | 912 | 50th |
Pharmaceutical Preparations | 715 | 48th |
Mellett's colleagues
We found four more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2018.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019